Memorial Sloan Kettering Suffolk -Commack (Limited Protocol Activities)
Memorial Sloan Kettering Suffolk -Commack (Limited Protocol Activities)
Commack, New York, United States4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer | Mesonephric Gynecologic Cancer | Active, not recruiting | Phase 2 | 2026-10-08 | NCT05787561 | |
| Pembrolizumab, Olaparib, and Temozolomide for People With Glioma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, epithelial neoplasm, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-07-22 | NCT05188508 | |
| A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer | Low-Grade Serous Ovarian Cancer | Recruiting | Phase 2 | 2026-07-20 | NCT06394804 | |
| A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy | Adnexal Diseases, Carcinoma, Ovarian Epithelial, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, carcinoma, endocrine system disorder, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Active, not recruiting | Phase 2 | 2026-02-27 | NCT06240598 |